Security: You Either Get It or You Don’t

Counterfeiting and diverting continue to challenge pharmaceutical manufacturers to come up with new and better ways to avoid each problem. “When you look at some of the blockbuster drugs that are coming on the market, drug companies are expecting $1 billion plus in revenues,” says Tom Jay, VP, sales and marketing of SICPA. “They don’t want to see it counterfeited. They don’t want to see it diverted.” According to Jay, to avoid counterfeiting and diverting, drug companies begin planning early for the security design of the labels and packaging.